Profiling of circulating T-cells with prognostic and predictive value in early and advanced stage PDAC

Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is a lethal malignancy with few treatment options. Despite the promising results of immunotherapy in various solid cancers, the efficacy of immunotherapy in PDAC is poor. Therefore, deciphering immune responses is pivotal for the development of novel...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Anastasia Xagara, Konstantina Vasilieva, Alexandros Kokkalis, Alexandros Lazarou, George Christodoulopoulos, Vasileios Papadopoulos, Evangelia Chantzara, Fillipos Koinis, Emmanouil Saloustros, Galatea Kallergi, Vassilis Georgoulias, Ioannis S. Pateras, Athanasios Kotsakis
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Springer 2025-10-01
Sarja:	Cancer Immunology, Immunotherapy
Aiheet:	PDAC T-cell exhaustion TCF1 PD-1
Linkit:	https://doi.org/10.1007/s00262-025-04190-1
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!